9AT: ARMISTICE CAPITAL LLC

other names

ARMISTICE CAPITAL LLC

Adviser Profile

As of Date	03/31/2026
Registration	SEC, Approved, 07/02/2015
Other registrations (1)	SEC, ERA - Withdrawn, 06/26/2015
ADV Location	NEW YORK, NY, United States
Contact Info	212 xxxxxxx
Websites

AUM^*	4,724,705,592 -20%
of that, discretionary	4,724,705,592 -20%
Private Fund GAV^*	4,724,705,592 -15%
Avg Account Size	1,574,901,864 -20%
SMA’s	No
Private Funds	3

Adviser Type

- Large advisory firm

Number of Employees 30 7%

of those in investment advisory functions 19 12%

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

SEC Fund Type	Count	GAV
Fund TypeHedge Fund	Count3	GAV$4,724,705,592

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser LEADENHALL CAPITAL PARTNERS	Hedge Fund2.6b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV2.6b	AUM5.7b	#Funds12
Adviser SKYVIEW INVESTMENT ADVISORS, LLC	Hedge Fund139.2m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund425.0k	Other Fund-	Total Private Fund GAV140.0m	AUM8.3b	#Funds9
Adviser SOUTHEASTERN ASSET MANAGEMENT INC.	Hedge Fund8.7m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV8.7m	AUM3.7b	#Funds1
Adviser CINCTIVE CAPITAL MANAGEMENT LP	Hedge Fund3.1b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV3.1b	AUM3.1b	#Funds6
Adviser CANDLESTICK CAPITAL MANAGEMENT LP	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM5.2b	#Funds-
Adviser SPX CAPITAL MANAGEMENT LLC	Hedge Fund2.8b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV2.8b	AUM350.0m	#Funds11
Adviser ALPHASIMPLEX GROUP, LLC	Hedge Fund860.2m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV860.2m	AUM3.1b	#Funds2
Adviser EMPYREAN CAPITAL PARTNERS, LP	Hedge Fund5.0b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV5.0b	AUM5.0b	#Funds4
Adviser GLAZER CAPITAL, LLC.	Hedge Fund10.0b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV10.0b	AUM6.8b	#Funds4
Adviser VR ADVISORY SERVICES LTD.	Hedge Fund9.6b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV9.6b	AUM9.8b	#Funds6

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker78462F103	Stock NameSTATE STR SPDR S&P 500 ETF T (PUT)	$ Position$1,365,714,000	% Position24.00%	$ Change67.00%	# Change75.00%
Stck Ticker464287655	Stock NameISHARES TR (PUT)	$ Position$868,000,000	% Position15.00%	$ Change-22.00%	# Change-22.00%
Stck Ticker69366J200	Stock NamePTC THERAPEUTICS INC	$ Position$141,332,210	% Position3.00%	$ Change-34.00%	# Change-26.00%
Stck Ticker89422G107	Stock NameTRAVERE THERAPEUTICS INC	$ Position$145,502,259	% Position3.00%	$ Change1.00%	# Change30.00%
Stck Ticker868459108	Stock NameSUPERNUS PHARMACEUTICALS	$ Position$97,970,486	% Position2.00%	$ Change-29.00%	# Change-31.00%
Stck Ticker64125C109	Stock NameNEUROCRINE BIOSCIENCES INC	$ Position$95,379,760	% Position2.00%	$ Change-18.00%	# Change-12.00%
Stck Ticker45258J102	Stock NameIMMUNOVANT INC	$ Position$88,552,513	% Position2.00%	$ Change-39.00%	# Change-38.00%
Stck Ticker00847X104	Stock NameAGIOS PHARMACEUTICALS INC	$ Position$91,882,280	% Position2.00%	$ Change11.00%	# Change-11.00%
Stck Ticker00847X104	Stock NameAGIOS PHARMACEUTICALS INC (CALL)	$ Position$108,256,000	% Position2.00%	$ Change33.00%	# Change7.00%
Stck Ticker023135106	Stock NameAMAZON COM INC	$ Position$54,595,273	% Position1.00%	$ Change-36.00%	# Change-29.00%

Brochure Summary

Overview

Armistice Capital, LLC (“Armistice”), a Delaware limited liability company, is an investment management firm located in New York that commenced operations on May 1, 2012. Steven J. Boyd (the “Managing Member”) is Armistice’s principal and majority owner. Armistice provides discretionary investment advisory services to private investment funds (the “Funds” or the “Advisory Clients”), which include: Armistice Capital Fund LP, a Delaware limited partnership that launched on July 1, 2012 (the “Domestic Fund”); Armistice Capital Offshore Fund Ltd., an exempted company incorporated under the laws of the Cayman Islands that launched on August 1, 2012 (the “Offshore Fund”); and Armistice Capital Master Fund Ltd., an exempted company incorporated under the laws of the Cayman Islands (the “Master Fund”) that launched on July 1, 2012. The Domestic Fund and the Offshore Fund (together, the “Feeder Funds”) invest substantially all of their assets in the Master Fund, through a master-feeder fund structure. It should also be noted that Armistice Capital GP, LLC (the “General Partner”), an affiliate of Armistice, is also majority owned by Mr. Boyd and acts as General Partner to the Domestic Fund. The Feeder Funds, through their investments in the Master Fund, seek to achieve long-term capital appreciation by employing an opportunistic global long/short strategy for investing primarily in equity securities, equity-related instruments, debt investments, and other assets. In all

of its investing activities, the Funds seek to emphasize capital preservation and seek to mitigate risk through various hedging strategies at both the position and portfolio levels. To achieve this objective, the Funds seek to focus on strategic value, event, and thematic investment opportunities (both long and short) in a variety of industries. It should be noted that the Funds invest a portion of their assets in illiquid investments (with some limitation), including, investments in securities of non-public companies. While it is anticipated that the Funds will continue to invest primarily in equities and equity-related securities in the both the U.S. and non-U.S. markets, Armistice has broad and flexible investment authority with respect to the Funds. The Funds have entered into and may in the future enter into agreements (“Side Letters”) with certain prospective or existing investors whereby such investors are subject to terms and conditions that are more advantageous than those set forth in the respective Fund’s offering documents. The modifications are solely at the discretion of Armistice and may, among other things, be based on the size of the investor’s investment in the Funds, an agreement by an investor to maintain such investment in the Funds for a significant period of time, or other similar commitment by an investor to the Funds. As of December 31, 2023, Armistice managed approximately $5,911,150,000of regulatory assets on a discretionary basis.

ARMISTICE CAPITAL LLC

Adviser Profile

Details

Adviser Type

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview